Your browser doesn't support javascript.
loading
Association of Bevacizumab Plus Oxaliplatin-Based Chemotherapy With Disease-Free Survival and Overall Survival in Patients With Stage II Colon Cancer: A Secondary Analysis of the AVANT Trial.
Chibaudel, Benoist; Henriques, Julie; Rakez, Manel; Brenner, Baruch; Kim, Tae Won; Martinez-Villacampa, Mercedes; Gallego-Plazas, Javier; Cervantes, Andres; Shim, Katharine; Jonker, Derek; Guerin-Meyer, Veronique; Mineur, Laurent; Banzi, Chiara; Dewdney, Alice; Dejthevaporn, Thitiya; Bloemendal, Haiko J; Roth, Arnaud; Moehler, Markus; Aranda, Enrique; Van Cutsem, Eric; Tabernero, Josep; Schmoll, Hans-Joachim; Hoff, Paulo M; André, Thierry; de Gramont, Aimery.
Afiliação
  • Chibaudel B; Department of Medical Oncology, Franco-British Hospital-Fondation Cognacq-Jay, Levallois-Perret, France.
  • Henriques J; Statistical Unit, Aide et Recherche en Cancérologie Digestive, Foundation, Levallois-Perret, France.
  • Rakez M; Methodology and Quality of Life Unit in Oncology, University Hospital of Besançon, Institut National de la Santé et de la Recherche Médicale, Unité Mixte de Recherche 1098, Besançon, France.
  • Brenner B; Statistical Unit, Aide et Recherche en Cancérologie Digestive, Foundation, Levallois-Perret, France.
  • Kim TW; Institute of Oncology, Davidoff Cancer Center, Rabin Medical Center, Petah Tiqva, Tel Aviv University, Tel Aviv, Israel.
  • Martinez-Villacampa M; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Gallego-Plazas J; Department of Medical Oncology, Institut Català d'Oncologia-Bellvitge Institute for Biomedical Research, L'Hospitalet, Barcelona, Spain.
  • Cervantes A; Department of Medical Oncology, General Universitario de Elche Hospital, Elche, Spain.
  • Shim K; Department of Medical Oncology, Hospital Clinico Universitario de Valencia, Valencia, Spain.
  • Jonker D; Department of Medical Oncology, Lakeridge Health R.S. McLaughlin Durham Regional Cancer Centre, Oshawa, Ontario, Canada.
  • Guerin-Meyer V; Division of Medical Oncology, Department of Medicine, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Canada.
  • Mineur L; Department of Gastroenterology and Hepatology, Institut de Cancérologie de l'Ouest Paul Papin, Angers, France.
  • Banzi C; Department of Radiotherapy and Oncology Gastrointestinal and Liver, Institut Sainte Catherine, Avignon, France.
  • Dewdney A; Medical Oncology Unit, Arcispedale Santa Maria Nuova-Istituto di Ricovero e Cura a Carattere Scientifico, Reggio Emilia, Italy.
  • Dejthevaporn T; Department of Oncology, Weston Park Hospital Cancer Research Centre, Sheffield, United Kingdom.
  • Bloemendal HJ; Medical Oncology Unit, Ramathibodi Hospital, Bangkok, Thailand.
  • Roth A; Department of Internal Medicine and Medical Oncology, Radboud University Medical Center, Nijmegen, Netherlands.
  • Moehler M; Digestive Tumor Unit, Department of Oncology, Hôpitaux Universitaires de Genève, Geneva, Switzerland.
  • Aranda E; First Department of Internal Medicine, University Hospital of Mainz, Mainz, Germany.
  • Van Cutsem E; Department of Medical Oncology, Reina Sofía University Hospital, Córdoba, Spain.
  • Tabernero J; Department of Gastroenterology and Digestive Oncology, University Hospitals Gasthuisberg/Leuven and KULeuven, Leuven, Belgium.
  • Schmoll HJ; Department of Medical Oncology, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Universitat de Vic-Universitat Central de Catalunya, International Oncology Bureau-Quiron, Barcelona, Spain.
  • Hoff PM; Department of Oncology and Hematology, Martin Luther University, Halle, Germany.
  • André T; Department of Radiology and Oncology, Instituto de Câncer do Estado de São Paulo, São Paulo, Brazil.
  • de Gramont A; Department of Medical Oncology, Hôpital Saint-Antoine, Assitance Publique des Hôpitaux de Paris, Paris, France.
JAMA Netw Open ; 3(10): e2020425, 2020 10 01.
Article em En | MEDLINE | ID: mdl-33074326

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oxaloacetatos / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias do Colo / Capecitabina / Bevacizumab Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oxaloacetatos / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias do Colo / Capecitabina / Bevacizumab Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article